The Department of Nuclear Medicine at the Fourth Affiliated Hospital of Zhejiang University School of Medicine was established in 2022. Over the course of three years, the department plans to establish a comprehensive nuclear diagnostic and therapeutic system, including SPECT and PET radionuclide imaging, as well as radioactive isotope therapy. The aim is to create a first-class discipline in molecular imaging and nuclear therapy in the central Zhejiang region.
Nuclear medicine employs minimal amounts of radiopharmaceuticals labeled with radioactive isotopes to diagnose diseases. It primarily reflects the local blood flow, function, and metabolism of lesions, enabling early detection of pathologies and assessment of treatment effects. It boasts characteristics such as non-invasiveness, safety, simplicity in the examination process, and high diagnostic accuracy. The field of nuclear medicine holds immense prospects for professional development, as it plays an increasingly vital role in clinical diagnosis and treatment through molecular-level functional imaging and isotope-specific targeted therapy. It stands as a hallmark of high-quality development in precision medicine.
The hospital has introduced the most advanced SPECT/CT imaging equipment from GE, featuring a unique spiral tomography acquisition model and algorithms. This equipment offers exceptional sensitivity, resolution, and scanning speed. The current range of examination projects conducted by the Department of Nuclear Medicine includes bone imaging, renal dynamic imaging, myocardial perfusion imaging, parathyroid imaging, salivary gland imaging, thyroid imaging, and more. The department is dedicated to providing patients and clinicians with high-quality, comprehensive, and patient-centric services. The department's staffing is well-structured, consisting of two chief physicians, one resident physician, two head nurses, and two technologists.
In the rapidly evolving field of nuclear medicine, there is unique value in its molecular-level diagnosis and treatment of malignant tumors. It also holds significant applications in various disciplines such as endocrinology, cardiovascular, hematology, and urology. As the department's technological capabilities continue to improve, it aims to offer higher quality services to the people of Yiwu and the central Zhejiang region.